205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.49%
Negative revenue growth while INTC stands at 13.57%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
13.22%
Gross profit growth at 50-75% of INTC's 22.03%. Martin Whitman would question if cost structure or brand is lagging.
597.37%
EBIT growth above 1.5x INTC's 34.25%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
634.21%
Operating income growth above 1.5x INTC's 34.25%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
215.38%
Net income growth above 1.5x INTC's 33.02%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
233.33%
EPS growth above 1.5x INTC's 33.33%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
233.33%
Diluted EPS growth above 1.5x INTC's 35.29%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.18%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.46%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
3.22%
Maintaining or increasing dividends while INTC cut them. John Neff might see a strong edge in shareholder returns.
82.20%
OCF growth under 50% of INTC's 639.60%. Michael Burry might suspect questionable revenue recognition or rising costs.
146.94%
FCF growth 50-75% of INTC's 274.58%. Martin Whitman would see if structural disadvantages exist in generating free cash.
9.50%
10Y revenue/share CAGR under 50% of INTC's 624.83%. Michael Burry would suspect a lasting competitive disadvantage.
-11.69%
Negative 5Y CAGR while INTC stands at 215.30%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-40.47%
Negative 3Y CAGR while INTC stands at 71.04%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
100.19%
Below 50% of INTC's 348.49%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
6.52%
3Y OCF/share CAGR under 50% of INTC's 378.40%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
43.07%
10Y net income/share CAGR of 43.07% while INTC is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
1.45%
Below 50% of INTC's 179.89%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-45.24%
Negative 3Y CAGR while INTC is 77.49%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
137.33%
5Y equity/share CAGR at 50-75% of INTC's 226.14%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
51.12%
Below 50% of INTC's 107.67%. Michael Burry suspects a serious short-term disadvantage in building book value.
93.58%
Dividend/share CAGR of 93.58% while INTC is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
33.51%
Below 50% of INTC's 152.21%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
2.52%
Below 50% of INTC's 60.59%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-11.07%
Firm’s AR is declining while INTC shows 16.31%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-19.26%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
2.61%
Asset growth at 75-90% of INTC's 3.41%. Bill Ackman suggests reviewing opportunities to match or surpass the competitor's asset expansion if profitable.
1.34%
1.25-1.5x INTC's 1.11%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-0.15%
We’re deleveraging while INTC stands at 8.54%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-4.90%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-31.95%
We cut SG&A while INTC invests at 14.16%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.